Daniel P Van Plew Regeneron Pharmaceuticals, Inc. (REGN) insider trading activity

Daniel P Van Plew is EVP & General Mgr Industrial O of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 34,792 shares of REGN, which is worth approximately $25.9 Million. The most recent transaction as insider was on Feb 22, 2022, when has been sold 40,000 shares (Common Stock) at a price of $399.66 per share, resulting in proceeds of $15,986,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.8K

2.71% 3M change

70.73% 12M change

Total Value Held $25.9 Million

Daniel P Van Plew Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 22 2022	BUY Exercise of conversion of derivative security	$15,986,400 $399.66 p/Share	40,000 Added 36.17%	70,578 Common Stock
Dec 11 2021	SELL Payment of exercise price or tax liability	$463,045 $664.34 p/Share	697 Reduced 2.23%	30,578 Common Stock
Dec 08 2021	BUY Grant, award, or other acquisition	-	4,344 Added 12.2%	31,275 Common Stock
Nov 16 2021	SELL Open market or private sale	$4,448,537 $656.32 p/Share	6,778 Reduced 20.11%	26,931 Common Stock
Nov 15 2021	SELL Payment of exercise price or tax liability	$11,689,413 $641.5 p/Share	18,222 Reduced 35.09%	33,709 Common Stock
Nov 15 2021	BUY Exercise of conversion of derivative security	$6,760,750 $270.43 p/Share	25,000 Added 32.5%	51,931 Common Stock
Aug 10 2021	SELL Open market or private sale	$4,037,074 $611.4 p/Share	6,603 Reduced 19.69%	26,931 Common Stock
Aug 09 2021	SELL Payment of exercise price or tax liability	$11,363,459 $617.68 p/Share	18,397 Reduced 35.43%	33,534 Common Stock
Aug 09 2021	BUY Exercise of conversion of derivative security	$6,760,750 $270.43 p/Share	25,000 Added 32.5%	51,931 Common Stock
Dec 09 2020	BUY Grant, award, or other acquisition	-	6,930 Added 20.47%	26,931 Common Stock
Aug 25 2020	SELL Open market or private sale	$16,590,165 $611.98 p/Share	27,109 Reduced 57.54%	20,001 Common Stock
Aug 20 2020	SELL Payment of exercise price or tax liability	$29,409,384 $614.09 p/Share	47,891 Reduced 50.41%	47,110 Common Stock
Aug 20 2020	BUY Exercise of conversion of derivative security	$13,434,750 $179.13 p/Share	75,000 Added 44.12%	95,001 Common Stock
May 07 2020	SELL Open market or private sale	$22,285,624 $563.01 p/Share	39,583 Reduced 58.35%	28,251 Common Stock
May 06 2020	SELL Payment of exercise price or tax liability	$25,563,196 $555.77 p/Share	45,996 Reduced 40.41%	67,834 Common Stock
May 06 2020	BUY Exercise of conversion of derivative security	$4,452,675 $52.03 p/Share	85,579 Added 47.12%	96,051 Common Stock
Feb 26 2020	SELL Open market or private sale	$7,132,595 $455.99 p/Share	15,642 Reduced 35.64%	28,251 Common Stock
Feb 25 2020	SELL Payment of exercise price or tax liability	$7,645,698 $447.3 p/Share	17,093 Reduced 28.03%	43,893 Common Stock
Feb 25 2020	BUY Exercise of conversion of derivative security	$1,002,673 $30.63 p/Share	32,735 Added 34.93%	60,986 Common Stock

DPV

Daniel P Van Plew

EVP & General Mgr Industrial O

Tarrytown, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Value

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN

Account